Diatom communities and ecological status classification in the upper Po River basin

One of the main challenges in river management is the setting of nutrient thresholds that support good ecological status, which is the main objective to achieve for the European member states. This is a complex process, which needs an accurate analysis of the data collected so far for the ecological classification of rivers belonging to different typologies. We analysed the data of the multiannual monitoring concerning diatoms and nutrients in the upper Po River (NW Italy) with the aim of exploring the response of diatom community in terms of species composition, ecological guilds and indices. We considered data of 390 samples, of which 2/3 belonging to the “Central macrotype” (i.e. lowland stretches) and 1/3 to “Alpine siliceous”. We performed a Principal Coordinate Analysis to detect community patterns with respect to water chemical classification and macrotypes highlighting species and ecological guilds characteristic of samples along a water quality gradient. We then performed a partial RDA to focus on the role of environmental and spatial factors in shaping the diatom community in each of the two macrotypes. Finally, we investigated the concordance between the Italian normative indices ICMi (for diatoms) and LIMECO (a chemical index of water quality). We found significant differences in the diatom communities of the two macrotypes and in their response to water quality and to spatial factors. Communities resulted as much more uniform in sites with a low water quality, with characteristic species such as Navicula gregaria, Nitzschia palea and Sellaphora nigri. On the other hands, moderately disturbed sites (in terms of trophic level) were characterised by the highest guild diversity. The RDA confirmed the importance of spatial factors in shaping the diatom assemblages, especially in Alpine streams where the physical barriers may condition species dispersion. The comparison between the two normative indices highlights that the correspondence in the classification is achieved in the 57% (Alpine macrotype) and 43% (Central macrotype) of samples. According to our findings, we suggest the revision of the ICMi, both class boundaries and reference value. In addition, we recommend to lower LIMECO threshold for total phosphorus: indeed, several studies have shown significant changes in the diatom community composition starting from very low values (below the current LIMECO threshold, i.e. 50 µgL-1). Moreover, the extension of our study to the whole Po River basin will complete our knowledge of species not yet included in the diatom indices and of the community response to nutrient levels also in other macrotypes

Rapamycin rescues mitochondrial dysfunction in cells carrying the m.8344A > G mutation in the mitochondrial tRNALys

Background: Myoclonus, Epilepsy and Ragged-Red-Fibers (MERRF) is a mitochondrial encephalomyopathy due to heteroplasmic mutations in mitochondrial DNA (mtDNA) most frequently affecting the tRNALys gene at position m.8344A > G. Defective tRNALys severely impairs mitochondrial protein synthesis and respiratory chain when a high percentage of mutant heteroplasmy crosses the threshold for full-blown clinical phenotype. Therapy is currently lim- ited to symptomatic management of myoclonic epilepsy, and supportive measures to counteract muscle weakness with co-factors/supplements. Methods: We tested two therapeutic strategies to rescue mitochondrial function in cybrids and fibroblasts carry- ing different loads of the m.8344A > G mutation. The first strategy was aimed at inducing mitochondrial biogenesis directly, over-expressing the master regulator PGC-1α, or indirectly, through the treatment with nicotinic acid, a NAD+ precursor. The second was aimed at stimulating the removal of damaged mitochondria through prolonged rapamy- cin treatment. Results: The first approach slightly increased mitochondrial protein expression and respiration in the wild type and intermediate-mutation load cells, but was ineffective in high-mutation load cell lines. This suggests that induction of mitochondrial biogenesis may not be sufficient to rescue mitochondrial dysfunction in MERRF cells with high-muta- tion load. The second approach, when administered chronically (4 weeks), induced a slight increase of mitochondrial respiration in fibroblasts with high-mutation load, and a significant improvement in fibroblasts with intermediate- mutation load, rescuing completely the bioenergetics defect. This effect was mediated by increased mitochondrial biogenesis, possibly related to the rapamycin-induced inhibition of the Mechanistic Target of Rapamycin Complex 1 (mTORC1) and the consequent activation of the Transcription Factor EB (TFEB). Conclusions: Overall, our results point to rapamycin-based therapy as a promising therapeutic option for MERRF